04: Blood Transfusions
| 4.1 | Assessing the need for routine transfusions |
| 4.2 | Baseline laboratory tests prior to regular transfusions |
| 4.3 | Transfusion administration and monitoring |
| 4.3.1 | Transfusion facility |
| 4.3.2 | Type of blood product |
| 4.3.3 | Target hemoglobin and frequency of transfusions |
| 4.4 | Adverse reactions to transfusions |
| 4.5 | Splenectomy |
| 4.6 | Thromboembolic Disease |
05: Iron Overload and Chelation Therapy
| 5.1 | Initiation of chelation |
| 5.2 | Treatment with iron chelators |
| 5.2.1 | Treatment with deferoxamine (Desferal) |
| 5.2.2 | Treatment with deferasirox (Exjade) |
| 5.2.3 | Treatment with deferiprone (L1/Ferriprox) |
| 5.3 | Patients with significant iron overload |
| 5.3.1 | High-dose, continuous deferoxamine |
| 5.3.2 | Combination therapy: deferoxamine and deferasirox |
| 5.3.3 | Combination therapy: deferoxamine and deferiprone |